Adam Seabrook

Synapticure brings expert virtual care to individuals and caregivers living with neurodegenerative diseases, including Parkinsons, Alzheimers and related dementia, ALS, and more conditions. Our mission is to democratize access to cutting-edge and personalized care provided by neurologists, mental health providers, and care navigators here for you 24/7.

Sift equips healthcare providers and revenue cycle managers with a complete payments analytics platform making it easy to visualize and understand payment trends, prioritize RCM workflows and accelerate cash flow. Sift improves data clarity and optimizes the financial performance of the entire revenue cycle continuum. Meaningful insights help reduce denials, increase patient payments, maximize reimbursements and reduce time and cost to collect. Revenue Cycle Optimization Solutions • Data Visualization Tools - Denials Dashbaord & Payments Dashbaord • AI-Driven Denials Management and Payment Management • C-Suite Intelligence Tools

Positive Development is dedicated to empowering neurodivergent children and teens with the skills they need to thrive and become high achievers. We offer more than a model of care; we embrace an approach that fosters childrens intellectual and emotional development, personal confidence and paving the way for lifelong success and happiness.

Healthcare needs good data. At PicnicHealth, we are building deep real-world datasets fueling cutting edge research while giving patients control of their own medical record data. These complete, clinically-rich datasets produce unique insights - across dozens of diseases - to ultimately get the right treatments into patients’ hands faster. We do this by working directly with patients and leveraging state of the art machine learning and human curation to transform messy medical records into structured, research-ready datasets. To date, we’ve helped tens of thousands of patients securely access their records and proactively contribute to advancing research in diseases that impacts their lives. We partner with some of the largest life sciences companies (including 10 of the Top 30) and have raised more than $100M including a recently closed $60M Series C led by B Capital Group, with continued investments from Felicis Ventures and Amplify Partners, who also participated in the Series B.

Aetion is a health care analytics company that delivers real-world evidence for the manufacturers, purchasers, and regulators of medical treatments and technologies. The Aetion Evidence Platform® analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on safety, effectiveness, and value. Founded by Harvard Medical School faculty members with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide product development, commercialization, and payment innovation. Aetion is based in New York City and backed by investors including New Enterprise Associates (NEA), Warburg Pincus, Flare Capital Partners, Greenspring Associates, Lakestar, B Capital, Foresite Capital, Town Hall Ventures, McKesson Ventures, Sanofi Ventures, EDBI, Johnson & Johnson Innovation—JJDC, Inc., UCB, Amgen Ventures, and Horizon Health Services, Inc. Learn more at aetion.com and follow us at @aetioninc.

Centivo is a new kind of healthcare company committed to restoring healthcare affordability for American employers and their people. Founded in 2017, Centivo’s model was designed specifically to curb the inefficiency and waste in today’s employer healthcare market. In partnership with leading local health systems, Centivo’s primary care-centered health plan offers U.S. employers a replacement to traditional health insurance carriers, lowering the total cost of care by 30% or more while delivering tangible value to employers, employees, and its partner health systems. Centivo delivers on its mission every day for its diverse employer clients across America – from local bakeries and schools to Fortune 100 enterprises.

Evidation creates new ways to measure and improve health in everyday life—making proactive, personalized, and truly human-centered healthcare possible. By connecting directly with millions of individuals, Evidation harnesses real-world data to deeply understand health experiences, rapidly and at scale. Evidation’s privacy-centric digital health measurement and engagement platform uses data science and machine learning to translate these everyday insights into high-impact health guidance, treatments, and tools. Founded in 2012, Evidation is headquartered in California with employees working around the globe.

SilverCloud® by Amwell® (NYSE: AMWL) is a leading digital mental health platform, enabling providers, health plans and employers to deliver clinically validated digital health/therapeutic care that improves outcomes and increases access and scale while reducing costs. Developed in Ireland in 2012, the multi-award-winning digital mental health platform is a result of 20 years of clinical research with leading academic institutions. Today, SilverCloud® is being used by more than 500 organizations globally to meet their populations’ mental health needs. Global experts have clinically proven the platform through fully randomized control trials and anonymized, real-world data from over one million SilverCloud users. The platform is a leader in the industry with its effectiveness, engagement and range of clinical programs that encompasses the spectrum of mental health needs.

Notable is a clinical-stage platform therapeutic company developing a new class of precision medicines: predictive precision medicines. Notable aims to be the leader in predictive precision medicine and revolutionize the way in which patients seek and receive treatment: patient population by patient population, and cancer by cancer. By transforming historical standards of care, Notable expects to provide dramatic impact for patients and the healthcare community. Notable’s proprietary Predictive Precision Medicines Platform replicates ex vivo the clinical response of patients to cancer treatments with high fidelity, through its optimized integration of biological assay conditions, dynamic signal analysis, and AI-driven in-silico translation into predictive algorithms. Using its high-fidelity platform, Notable can identify and select clinically responsive patients prior to their treatment and fast-track clinical development in this patient population. Notable has created a targeted, triple de-risked in-licensing strategy and a fast-track clinical development approach that delivers a product’s medical impact and commercial value faster, higher, and more likely than traditional drug development.

Atomwise is a preclinical pharma company revolutionizing how drugs are discovered with AI. Atomwise has strengthened its drug discovery and development expertise by expanding its Board of Directors and creating a Scientific Advisory Board (SAB). These appointments signal a critical milestone for Atomwise as the company focuses on its own internal pipeline. We invented the use of deep learning for structure-based drug discovery, today developing a pipeline of small-molecule drug candidates advancing into preclinical studies. Our AtomNet® technology has been used to unlock more undruggable targets than any other AI drug discovery platform. We are tackling over 600 unique disease targets with more than 250 partners around the world, including leading pharmaceutical, agrochemical, and emerging biotechnology companies. Atomwise has raised over $174 million from leading venture capital firms to advance our mission to make better medicines, faster. We’re at a critical time in history where our need for new kinds of medicines is greater than any time in human memory. Fortunately, we can leverage advancing technology and scientific breakthroughs to accelerate discovery. New data, new algorithms, new compute platforms lift all of us, enable our work on the hardest of problems, empower us to invent and create, and ultimately save one billion lives. Join us: www.atomwise.com/careers

Making Healthy Happen Faster. Bright.md is the leading virtual care solution trusted by health systems to automate clinical workflows and administrative tasks, improving patient and provider engagement and driving operational efficiency. With its pioneering technology, Bright.md improves how health systems deliver care, from patient acquisition through clinical interview and treatment, to reduce 90% of administrative workflows, lower patient wait-times to 6 minutes on average, and drive patient loyalty with industry-leading satisfaction ratings. Founded in 2014 and based in Portland, Oregon, Bright.md has been named a Gartner Cool Vendor in Healthcare, a Vendor to Watch by Chilmark Research, and is the preferred choice of AVIA’s Virtual Access cohort. Bright.md is backed by B Capital Group, Seven Peaks Ventures, Pritzker Group Venture Capital, Philips Health Technology Ventures, UnityPoint Health, and Concord Health Partners.

SilverCloud® by Amwell® (NYSE: AMWL) is a leading digital mental health platform, enabling providers, health plans and employers to deliver clinically validated digital health/therapeutic care that improves outcomes and increases access and scale while reducing costs. Developed in Ireland in 2012, the multi-award-winning digital mental health platform is a result of 20 years of clinical research with leading academic institutions. Today, SilverCloud® is being used by more than 500 organizations globally to meet their populations’ mental health needs. Global experts have clinically proven the platform through fully randomized control trials and anonymized, real-world data from over one million SilverCloud users. The platform is a leader in the industry with its effectiveness, engagement and range of clinical programs that encompasses the spectrum of mental health needs.

Evidation creates new ways to measure and improve health in everyday life—making proactive, personalized, and truly human-centered healthcare possible. By connecting directly with millions of individuals, Evidation harnesses real-world data to deeply understand health experiences, rapidly and at scale. Evidation’s privacy-centric digital health measurement and engagement platform uses data science and machine learning to translate these everyday insights into high-impact health guidance, treatments, and tools. Founded in 2012, Evidation is headquartered in California with employees working around the globe.

Synapticure brings expert virtual care to individuals and caregivers living with neurodegenerative diseases, including Parkinsons, Alzheimers and related dementia, ALS, and more conditions. Our mission is to democratize access to cutting-edge and personalized care provided by neurologists, mental health providers, and care navigators here for you 24/7.

Sift equips healthcare providers and revenue cycle managers with a complete payments analytics platform making it easy to visualize and understand payment trends, prioritize RCM workflows and accelerate cash flow. Sift improves data clarity and optimizes the financial performance of the entire revenue cycle continuum. Meaningful insights help reduce denials, increase patient payments, maximize reimbursements and reduce time and cost to collect. Revenue Cycle Optimization Solutions • Data Visualization Tools - Denials Dashbaord & Payments Dashbaord • AI-Driven Denials Management and Payment Management • C-Suite Intelligence Tools

Positive Development is dedicated to empowering neurodivergent children and teens with the skills they need to thrive and become high achievers. We offer more than a model of care; we embrace an approach that fosters childrens intellectual and emotional development, personal confidence and paving the way for lifelong success and happiness.

Healthcare needs good data. At PicnicHealth, we are building deep real-world datasets fueling cutting edge research while giving patients control of their own medical record data. These complete, clinically-rich datasets produce unique insights - across dozens of diseases - to ultimately get the right treatments into patients’ hands faster. We do this by working directly with patients and leveraging state of the art machine learning and human curation to transform messy medical records into structured, research-ready datasets. To date, we’ve helped tens of thousands of patients securely access their records and proactively contribute to advancing research in diseases that impacts their lives. We partner with some of the largest life sciences companies (including 10 of the Top 30) and have raised more than $100M including a recently closed $60M Series C led by B Capital Group, with continued investments from Felicis Ventures and Amplify Partners, who also participated in the Series B.

Aetion is a health care analytics company that delivers real-world evidence for the manufacturers, purchasers, and regulators of medical treatments and technologies. The Aetion Evidence Platform® analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on safety, effectiveness, and value. Founded by Harvard Medical School faculty members with decades of experience in epidemiology and health outcomes research, Aetion informs health care’s most critical decisions — what works best, for whom, and when — to guide product development, commercialization, and payment innovation. Aetion is based in New York City and backed by investors including New Enterprise Associates (NEA), Warburg Pincus, Flare Capital Partners, Greenspring Associates, Lakestar, B Capital, Foresite Capital, Town Hall Ventures, McKesson Ventures, Sanofi Ventures, EDBI, Johnson & Johnson Innovation—JJDC, Inc., UCB, Amgen Ventures, and Horizon Health Services, Inc. Learn more at aetion.com and follow us at @aetioninc.